Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
14
LFMD Quote, Financials, Valuation and Earnings
Last price:
$3.42
Seasonality move
:
13.67%
Day range:
$3.36 - $3.50
52-week range:
$3.18 - $15.84
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.60x
P/B ratio:
124.91x
Volume:
870.1K
Avg. volume:
1.5M
1-year change:
-31.11%
Market cap:
$164.1M
Revenue:
$212.5M
EPS (TTM):
-$0.17
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LFMD
LifeMD, Inc.
|
$48.6M | $0.01 | -24.41% | -93.33% | $9.25 |
|
CDT
CDT Equity, Inc.
|
-- | -- | -- | -- | -- |
|
MDRX
Veradigm, Inc.
|
$149.7M | $0.08 | -- | -- | $5.83 |
|
SMLR
Semler Scientific, Inc.
|
$3.4M | -$0.54 | -72.52% | -91.67% | $65.67 |
|
STRM
Streamline Health Solutions,
|
$5.3M | -- | -24.87% | -- | $22.50 |
|
TBRG
TruBridge, Inc.
|
$87.6M | $0.66 | 0.28% | -28.23% | $22.60 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LFMD
LifeMD, Inc.
|
$3.41 | $9.25 | $164.1M | -- | $0.00 | 0% | 0.60x |
|
CDT
CDT Equity, Inc.
|
$1.28 | -- | $2.1M | -- | $0.00 | 0% | -- |
|
MDRX
Veradigm, Inc.
|
$4.80 | $5.83 | $519.7M | -- | $0.00 | 0% | 0.89x |
|
SMLR
Semler Scientific, Inc.
|
$15.29 | $65.67 | $231.8M | 5.50x | $0.00 | 0% | 4.98x |
|
STRM
Streamline Health Solutions,
|
$5.34 | $22.50 | $23.3M | -- | $0.00 | 0% | 1.18x |
|
TBRG
TruBridge, Inc.
|
$22.07 | $22.60 | $331.2M | 118.40x | $0.00 | 0% | 0.92x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LFMD
LifeMD, Inc.
|
83.24% | 2.884 | 2.29% | 0.58x |
|
CDT
CDT Equity, Inc.
|
30.47% | -0.944 | 27% | 1.13x |
|
MDRX
Veradigm, Inc.
|
-- | 0.948 | -- | -- |
|
SMLR
Semler Scientific, Inc.
|
4.17% | 2.857 | 4.4% | 0.49x |
|
STRM
Streamline Health Solutions,
|
55.84% | 4.014 | 109.22% | 0.25x |
|
TBRG
TruBridge, Inc.
|
48.06% | -0.370 | 55.15% | 1.44x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LFMD
LifeMD, Inc.
|
$50M | -$2M | -15.29% | -- | -3.27% | -$3.7M |
|
CDT
CDT Equity, Inc.
|
-$885K | -$7M | -898.82% | -- | -- | -$4.4M |
|
MDRX
Veradigm, Inc.
|
-- | -- | -- | -- | -- | -- |
|
SMLR
Semler Scientific, Inc.
|
$6.9M | -$5.4M | 18.02% | 18.3% | -71.95% | -$81.9M |
|
STRM
Streamline Health Solutions,
|
$2.6M | -$1.1M | -33.65% | -64.34% | -22.91% | -$1.2M |
|
TBRG
TruBridge, Inc.
|
$37.3M | $7.8M | 0.81% | 1.61% | 9.01% | $9.3M |
LifeMD, Inc. vs. Competitors
-
Which has Higher Returns LFMD or CDT?
CDT Equity, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of --. LifeMD, Inc.'s return on equity of -- beat CDT Equity, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFMDLifeMD, Inc.83.06% -$0.10 $9.9M CDTCDT Equity, Inc.-- -$13.16 $6.2M -
What do Analysts Say About LFMD or CDT?
LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 171.26%. On the other hand CDT Equity, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that LifeMD, Inc. has higher upside potential than CDT Equity, Inc., analysts believe LifeMD, Inc. is more attractive than CDT Equity, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LFMDLifeMD, Inc.7 1 0 CDTCDT Equity, Inc.0 0 0 -
Is LFMD or CDT More Risky?
LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison CDT Equity, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock LFMD or CDT?
LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CDT Equity, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. CDT Equity, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFMD or CDT?
LifeMD, Inc. quarterly revenues are $60.2M, which are larger than CDT Equity, Inc. quarterly revenues of --. LifeMD, Inc.'s net income of -$3.6M is higher than CDT Equity, Inc.'s net income of -$7.1M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while CDT Equity, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.60x versus -- for CDT Equity, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFMDLifeMD, Inc.0.60x -- $60.2M -$3.6M CDTCDT Equity, Inc.-- -- -- -$7.1M
-
Which has Higher Returns LFMD or MDRX?
Veradigm, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of --. LifeMD, Inc.'s return on equity of -- beat Veradigm, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFMDLifeMD, Inc.83.06% -$0.10 $9.9M MDRXVeradigm, Inc.-- -- -- -
What do Analysts Say About LFMD or MDRX?
LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 171.26%. On the other hand Veradigm, Inc. has an analysts' consensus of $5.83 which suggests that it could grow by 21.53%. Given that LifeMD, Inc. has higher upside potential than Veradigm, Inc., analysts believe LifeMD, Inc. is more attractive than Veradigm, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LFMDLifeMD, Inc.7 1 0 MDRXVeradigm, Inc.1 2 0 -
Is LFMD or MDRX More Risky?
LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison Veradigm, Inc. has a beta of 0.510, suggesting its less volatile than the S&P 500 by 49.042%.
-
Which is a Better Dividend Stock LFMD or MDRX?
LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veradigm, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Veradigm, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFMD or MDRX?
LifeMD, Inc. quarterly revenues are $60.2M, which are larger than Veradigm, Inc. quarterly revenues of --. LifeMD, Inc.'s net income of -$3.6M is higher than Veradigm, Inc.'s net income of --. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Veradigm, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.60x versus 0.89x for Veradigm, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFMDLifeMD, Inc.0.60x -- $60.2M -$3.6M MDRXVeradigm, Inc.0.89x -- -- --
-
Which has Higher Returns LFMD or SMLR?
Semler Scientific, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of -732.34%. LifeMD, Inc.'s return on equity of -- beat Semler Scientific, Inc.'s return on equity of 18.3%.
Company Gross Margin Earnings Per Share Invested Capital LFMDLifeMD, Inc.83.06% -$0.10 $9.9M SMLRSemler Scientific, Inc.91.51% $1.07 $479.7M -
What do Analysts Say About LFMD or SMLR?
LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 171.26%. On the other hand Semler Scientific, Inc. has an analysts' consensus of $65.67 which suggests that it could grow by 329.48%. Given that Semler Scientific, Inc. has higher upside potential than LifeMD, Inc., analysts believe Semler Scientific, Inc. is more attractive than LifeMD, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LFMDLifeMD, Inc.7 1 0 SMLRSemler Scientific, Inc.2 0 0 -
Is LFMD or SMLR More Risky?
LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison Semler Scientific, Inc. has a beta of 1.316, suggesting its more volatile than the S&P 500 by 31.636%.
-
Which is a Better Dividend Stock LFMD or SMLR?
LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Semler Scientific, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Semler Scientific, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFMD or SMLR?
LifeMD, Inc. quarterly revenues are $60.2M, which are larger than Semler Scientific, Inc. quarterly revenues of $7.5M. LifeMD, Inc.'s net income of -$3.6M is lower than Semler Scientific, Inc.'s net income of $16.9M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Semler Scientific, Inc.'s PE ratio is 5.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.60x versus 4.98x for Semler Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFMDLifeMD, Inc.0.60x -- $60.2M -$3.6M SMLRSemler Scientific, Inc.4.98x 5.50x $7.5M $16.9M
-
Which has Higher Returns LFMD or STRM?
Streamline Health Solutions, has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of -34.2%. LifeMD, Inc.'s return on equity of -- beat Streamline Health Solutions,'s return on equity of -64.34%.
Company Gross Margin Earnings Per Share Invested Capital LFMDLifeMD, Inc.83.06% -$0.10 $9.9M STRMStreamline Health Solutions,53.85% -$0.40 $25M -
What do Analysts Say About LFMD or STRM?
LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 171.26%. On the other hand Streamline Health Solutions, has an analysts' consensus of $22.50 which suggests that it could fall by -71.91%. Given that LifeMD, Inc. has higher upside potential than Streamline Health Solutions,, analysts believe LifeMD, Inc. is more attractive than Streamline Health Solutions,.
Company Buy Ratings Hold Ratings Sell Ratings LFMDLifeMD, Inc.7 1 0 STRMStreamline Health Solutions,1 0 0 -
Is LFMD or STRM More Risky?
LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison Streamline Health Solutions, has a beta of 2.070, suggesting its more volatile than the S&P 500 by 106.993%.
-
Which is a Better Dividend Stock LFMD or STRM?
LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Streamline Health Solutions, offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Streamline Health Solutions, pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFMD or STRM?
LifeMD, Inc. quarterly revenues are $60.2M, which are larger than Streamline Health Solutions, quarterly revenues of $4.8M. LifeMD, Inc.'s net income of -$3.6M is lower than Streamline Health Solutions,'s net income of -$1.6M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Streamline Health Solutions,'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.60x versus 1.18x for Streamline Health Solutions,. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFMDLifeMD, Inc.0.60x -- $60.2M -$3.6M STRMStreamline Health Solutions,1.18x -- $4.8M -$1.6M
-
Which has Higher Returns LFMD or TBRG?
TruBridge, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of 6.3%. LifeMD, Inc.'s return on equity of -- beat TruBridge, Inc.'s return on equity of 1.61%.
Company Gross Margin Earnings Per Share Invested Capital LFMDLifeMD, Inc.83.06% -$0.10 $9.9M TBRGTruBridge, Inc.43.35% $0.37 $347.2M -
What do Analysts Say About LFMD or TBRG?
LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 171.26%. On the other hand TruBridge, Inc. has an analysts' consensus of $22.60 which suggests that it could grow by 2.4%. Given that LifeMD, Inc. has higher upside potential than TruBridge, Inc., analysts believe LifeMD, Inc. is more attractive than TruBridge, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LFMDLifeMD, Inc.7 1 0 TBRGTruBridge, Inc.2 3 0 -
Is LFMD or TBRG More Risky?
LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison TruBridge, Inc. has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.29%.
-
Which is a Better Dividend Stock LFMD or TBRG?
LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TruBridge, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. TruBridge, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFMD or TBRG?
LifeMD, Inc. quarterly revenues are $60.2M, which are smaller than TruBridge, Inc. quarterly revenues of $86.1M. LifeMD, Inc.'s net income of -$3.6M is lower than TruBridge, Inc.'s net income of $5.4M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while TruBridge, Inc.'s PE ratio is 118.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.60x versus 0.92x for TruBridge, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFMDLifeMD, Inc.0.60x -- $60.2M -$3.6M TBRGTruBridge, Inc.0.92x 118.40x $86.1M $5.4M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 1
Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.
Buy
75
AXSM alert for Jan 1
Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.
Buy
81
ZIJMY alert for Jan 1
Zijin Mining Group Co., Ltd. [ZIJMY] is up 1.86% over the past day.
